Related Experiment Video
Updated: Dec 8, 2025

Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments
Published on: February 7, 2025
Protein Glycosylation: "New-yet-Old" Target for Immunotherapy
Jaydeep Bhat1, Dieter Kabelitz2
1Metabolic Programming, TUM School of Life Sciences Weihenstephan; ZIEL-Institute for Food and Health, Technical University of Munich (TUM), Freising, Germany. bhatvjay24@gmail.com dietrich.kabelitz@uksh.de.
Abstract:
The use of checkpoint monotherapy in treating cancer has limited success. Post-translational modifications (PTM) of proteins such as glycosylation might have clinical implications due to distinct modifications found in diseases and its regulatory role in the immunometabolic gene expression. Such novel mechanistic targets hold great promise for combined immunotherapy.See related article by Shi et al., p. 5990.
Insights
Checkpoint monotherapy shows limited cancer treatment success. Exploring protein glycosylation, a post-translational modification, offers new targets for effective combined immunotherapy strategies.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Background:
- Checkpoint monotherapy has shown limited efficacy in cancer treatment.
- Post-translational modifications (PTMs) like glycosylation play crucial roles in disease pathology.
- PTMs regulate immunometabolic gene expression, influencing the tumor microenvironment.
Purpose of the Study:
- To explore the potential of protein glycosylation as a therapeutic target in cancer.
- To investigate the role of distinct glycosylation patterns in disease.
- To identify novel mechanistic targets for combined immunotherapy.
Main Methods:
- Analysis of distinct protein glycosylation patterns in disease states.
- Investigating the regulatory role of glycosylation in immunometabolic gene expression.
- Evaluating glycosylation as a target for enhancing immunotherapy.
Main Results:
- Specific glycosylation patterns are associated with distinct disease characteristics.
- Glycosylation significantly influences immunometabolic gene expression.
- Targeting glycosylation presents a promising strategy for combined immunotherapy.
Conclusions:
- Protein glycosylation is a critical factor in cancer and immune response.
- Novel therapeutic strategies can be developed by targeting protein glycosylation.
- Combined immunotherapy approaches targeting glycosylation may overcome limitations of current treatments.
More Related Videos
Related Concept Videos
Protein Glycosylation
Glycosylation occurs in...
Proteoglycans
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Matrix Proteoglycans and Glycoproteins

